ID   CDS11
AC   CVCL_WJ30
DR   cancercelllines; CVCL_WJ30
DR   Wikidata; Q93445958
RX   PubMed=30987403;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=30987403).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Leu (c.395G>T); ClinVar=VCV000375889; Zygosity=Heterozygous (PubMed=30987403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=30987403).
ST   Source(s): PubMed=30987403
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D7S820: 11,12
ST   D5S818: 11,12
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 15
DI   NCIt; C27482; Secondary chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
RX   PubMed=30987403; DOI=10.3390/jcm8040455; PMCID=PMC6518242;
RA   Rey V., Menendez S.T., Estupinan O., Rodriguez A., Santos L.,
RA   Tornin Cavielles J., Martinez-Cruzado L., Castillo D., Ordonez G.R.,
RA   Costilla S., Alvarez-Fernandez C., Astudillo A., Brana A.,
RA   Rodriguez-Oviedo R.;
RT   "New chondrosarcoma cell lines with preserved stem cell properties to
RT   study the genomic drift during in vitro/in vivo growth.";
RL   J. Clin. Med. 8:455.1-455.19(2019).
//